Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (211-220 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|January 9, 2015
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissectionHitokazu Esaki, David A Ewald, Benjamin Ungar, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2020
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasisHelen He, Robert Bissonnette, Jianni Wu, et al.
Journal of the American Academy of Dermatology|November 29, 2025
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trialAthanasios Tsianakas, Thierry Passeron, Nina Magnolo, et al.
Allergy|March 13, 2026
Non-Invasive Scalp Tape-Strip RNA Sequencing Captures Disease Activity and Treatment-Response Signatures in Alopecia AreataCarmen Mochón-Jiménez, Jesús Gay-Mimbrera, Viviana Dávila-Flores, et al.
Journal of the American Academy of Dermatology|March 24, 2021
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week resultsBrett King, Emma Guttman-Yassky, Elena Peeva, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2012
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJulia K Gittler, Avner Shemer, Mayte Suárez-Fariñas, et al.
Allergy|April 5, 2021
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitisTali Czarnowicki, Hyun Je Kim, Axel P Villani, et al.
JAMA Dermatology|October 10, 2019
Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic DermatitisEmma Guttman-Yassky, Aisleen Diaz, Ana B Pavel, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2020
Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalitiesHelen He, Ester Del Duca, Aisleen Diaz, et al.
The New England Journal of Medicine|March 15, 2023
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, et al.
Pageof 39

Showing results (211-220 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|January 9, 2015
Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissectionHitokazu Esaki, David A Ewald, Benjamin Ungar, et al.
The Journal of Allergy and Clinical Immunology|July 26, 2020
Tape strips detect distinct immune and barrier profiles in atopic dermatitis and psoriasisHelen He, Robert Bissonnette, Jianni Wu, et al.
Journal of the American Academy of Dermatology|November 29, 2025
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trialAthanasios Tsianakas, Thierry Passeron, Nina Magnolo, et al.
Allergy|March 13, 2026
Non-Invasive Scalp Tape-Strip RNA Sequencing Captures Disease Activity and Treatment-Response Signatures in Alopecia AreataCarmen Mochón-Jiménez, Jesús Gay-Mimbrera, Viviana Dávila-Flores, et al.
Journal of the American Academy of Dermatology|March 24, 2021
A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week resultsBrett King, Emma Guttman-Yassky, Elena Peeva, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2012
Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitisJulia K Gittler, Avner Shemer, Mayte Suárez-Fariñas, et al.
Allergy|April 5, 2021
High-dimensional analysis defines multicytokine T-cell subsets and supports a role for IL-21 in atopic dermatitisTali Czarnowicki, Hyun Je Kim, Axel P Villani, et al.
JAMA Dermatology|October 10, 2019
Use of Tape Strips to Detect Immune and Barrier Abnormalities in the Skin of Children With Early-Onset Atopic DermatitisEmma Guttman-Yassky, Aisleen Diaz, Ana B Pavel, et al.
The Journal of Allergy and Clinical Immunology|October 4, 2020
Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalitiesHelen He, Ester Del Duca, Aisleen Diaz, et al.
The New England Journal of Medicine|March 15, 2023
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Emma Guttman-Yassky, Diamant Thaçi, et al.
Pageof 39